drugset / Trial / NCT00553553

Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery

NCT00553553

RandomizedParallel-groupSingle-blindTreatment

Summary

The patient population requiring hepatic resection can demonstrate an unpredictable risk of exhibiting peri-operative coagulopathy resulting either from the pre-operative hepatic pathophysiology or volume of parenchymal resection. Choice of analgesia can be severely limited. Currently, the most commonly described use of combined remifentanil infusion and intrathecal morphine has been in fast-track cardiac surgery. To date, there are no published data describing its use in the context of major hepatobiliary where the investigators predict it may provide adequate analgesia with a lower rate of adverse effects over the first 24 hours after surgery.

Timeline

Start
2007-09
Primary completion
2008-05
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 10 ug/kg Intravenous
Subject Morphine Other / unclassified 0.25 mg/kg Intravenous
Subject Remifentanil Small molecule 0.1 ug/kg Intravenous
Subject Remifentanil Small molecule 0.25 ug/kg Intravenous

Indications